Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HTX-011 for post-operative analgesia after abdominoplasty
NCT02689258Phase 2Completed
- Sponsor
- Heron Therapeutics, Inc.
- Start
- Feb 2016
- Primary completion
- Mar 2017
- Countries
- 1
01
Overview
A Phase 2 trial of bupivacaine + meloxicam in postoperative pain, sponsored by Heron Therapeutics, Inc.. Started Feb 2016; status: completed.
02
Drugs
bupivacaine + meloxicam
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02689258.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02689258.